India's Shilpa Medicare gains as unit gets European regulator nod for drug

Shilpa Medicare

19/11/2024 04:28

** Shares of Shilpa Medicare  SHME.NS  up 3.3% at 891 rupees
    ** SHME on Monday said its unit received regulatory nod from
the European Directorate for the Quality of Medicines &
Healthcare for its for its drug Octreotide
    ** The drug is used to treat severe diarrhea in some tumor
patients
    ** SHME shares up ~ 171% so far this year; pharma index
 .NIPHARM  up 29%

 (Reporting by Sethuraman NR)
 ((Sethuraman.NR@thomsonreuters.com; (+91 9945291420); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))